Company Profile
HVIVO is a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America. It provides end-to-end early clinical development services to the biopharmaceutical industry, including phase I capabilities and world leading human challenge trial services.
The company is involved in the testing of vaccines and antivirals using human challenge clinical trials; and provision of laboratory services, including virology, immunology and biomarker analysis
Assay development, sample analysis, and data interpretation, as well as services combined with specialisms in infectious diseases, respiratory, and cardiometabolic therapeutical areas.
It also provides preclinical and early clinical research services. Its portfolio also includes sales and marketing services, data management, storage solutions, and statistics services, as well as drug development consultancy and services. Formerly known as Open Orphan Plc, the company rebranded as hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.